- Home
- TRML vs LVWR Comparison
TRML vs LVWR Comparison
Compare TRML & LVWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRML
- LVWR
- Stock Information
- Founded
- TRML 2021
- LVWR 2022
- Country
- TRML United States
- LVWR United States
- Employees
- TRML N/A
- LVWR N/A
- Industry
- TRML Biotechnology: Pharmaceutical Preparations
- LVWR
- Sector
- TRML Health Care
- LVWR
- Exchange
- TRML Nasdaq
- LVWR Nasdaq
- Market Cap
- TRML 598.9M
- LVWR 706.4M
- IPO Year
- TRML N/A
- LVWR N/A
- Fundamental
- Price
- TRML $22.75
- LVWR $3.89
- Analyst Decision
- TRML Strong Buy
- LVWR
- Analyst Count
- TRML 7
- LVWR 0
- Target Price
- TRML $50.14
- LVWR N/A
- AVG Volume (30 Days)
- TRML 145.9K
- LVWR 110.1K
- Earning Date
- TRML 08-13-2025
- LVWR 10-23-2025
- Dividend Yield
- TRML N/A
- LVWR N/A
- EPS Growth
- TRML N/A
- LVWR N/A
- EPS
- TRML N/A
- LVWR N/A
- Revenue
- TRML N/A
- LVWR $23,822,000.00
- Revenue This Year
- TRML N/A
- LVWR $249.13
- Revenue Next Year
- TRML N/A
- LVWR $98.53
- P/E Ratio
- TRML N/A
- LVWR N/A
- Revenue Growth
- TRML N/A
- LVWR N/A
- 52 Week Low
- TRML $11.56
- LVWR $0.93
- 52 Week High
- TRML $29.79
- LVWR $9.04
- Technical
- Relative Strength Index (RSI)
- TRML 67.63
- LVWR 53.77
- Support Level
- TRML $22.57
- LVWR $3.60
- Resistance Level
- TRML $24.56
- LVWR $4.14
- Average True Range (ATR)
- TRML 1.05
- LVWR 0.36
- MACD
- TRML 0.02
- LVWR 0.06
- Stochastic Oscillator
- TRML 84.76
- LVWR 79.17
About TRML Tourmaline Bio Inc.
Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.
About LVWR LiveWire Group Inc.
LiveWire Group Inc is an all-electric vehicle company. It sells electric vehicles and related parts and accessories and apparel in the United States and certain international markets. The company's segment includes Electric Motorcycles and STACYC. Electric Motorcycles segment sells electric motorcycles, related parts and accessories and apparel in the United States and certain international markets; STACYC segment sells electric balance bikes for kids, related parts and accessories and apparel in the United States and certain international markets. LiveWire generates revenue from the sale of electric motorcycles, Parts, accessories and apparel. Majority of revenue is from USA.